Drug Shortage Report for SODIUM CHLORIDE INJ 23.4%
| Report ID | 2131 |
| Drug Identification Number | 00402230 |
| Brand name | SODIUM CHLORIDE INJ 23.4% |
| Common or Proper name | Sodium Chloride Injection USP 23.4% |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM CHLORIDE |
| Strength(s) | 234MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 30mL vial |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-09-19 |
| Estimated end date | 2017-04-15 |
| Actual end date | 2017-03-29 |
| Shortage status | Resolved |
| Updated date | 2017-06-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2017-06-19 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v1 | 2017-03-14 | English | Compare |
Showing 1 to 3 of 3